Research Site

Oxford, Oxfordshire OX3 9DU

1 studies enrolling now · 3 studies all time

What they study most

Hypophosphatasia (HPP), Multiple Sclerosis, Parkinson's Disease

Studies at this site

• Registry of Patients With Hypophosphatasia — Enrolling by invitation
• Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS) — Stopped early
• Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease — Stopped early